» Download Public Reports
90 reports
- Company report
- May 2013
- 10 pages
January 2013
... generic medicines industry faces strong competition from trional producers such as the us and japan, along with growing competition from fast developing emerging market economies from the brick7 ...
December 2012
... Growth outlook moderate with generic penetration already over 80% Europe: impact of crisis on demand Increasing competition from lower cost providers accelerating price erosion Global pricing ...
December 2012
... Of international competition 20 year patent + up to 5 year spc leading countries in number of cans for biosimilars european generic medicines industry: major contributor to employment ...
December 2012
... generic medicines company source: ega and ec - sector inquiry unsustainable challenge more regulation/ increased costs price decrease national level national + eu level 26 positive trends ...
December 2012
... The supreme court will take up Pay for delay The multibillion-dollar dispute over whether brand-name drug makers should be able to pay generic drug companies for agreeing to delay putting cheaper versions ...
November 2012
... Potential generic equivalents), potential liability for sales of generic medicines prior to a final resolution of outstanding patent litigation, including that relating to our generic version of protonix ...